Mobile Diagnostic Ultrasound Service in New York City

at We Are a Mobile Ultrasound Company, So We Come to You and Your Clinic at a Time, During the Week, That Is Most Convenient to You and Your Patient'S Schedule , 10002

We are a mobile ultrasound company,so we come to you and your clinic at a time, during the week, that is most convenient to you and your patient’s schedule


Mobile Diagnostic Ultrasound Service in New York City
We Are a Mobile Ultrasound Company, So We Come to You and Your Clinic at a Time, During the Week, That Is Most Convenient to You and Your Patient'S Schedule
New York , NY 10002
United States
Contact Phone
P: (917) 548-8877
Website
http://www.proultrasoundservice.com

Description

We are an established, Mobile Ultrasound company. We Help Internal medicine and Family practice Physicians start an Ultrasound department in their private offices. Services we provide: Echocardiograms (Sono of the heart), Carotid, TCD- trans-cranial Doppler, Arterial and Venous Doppler's of upper and lower extremities, (R/O plaque "PVD" and blood clots DVT" and stroke screenings) Abdominal and renal Sono's (Liver functions, gall bladder disease, pancreas and Kidney disorders, Renal arteries Doppler and AAA "aortic Aneurysms screenings). Thyroid, male and female Pelvic (prostate, uterus, bladder and Ovaries) NCV, NCT (Nerve Conduction Test). We accept most insurances as payment in full, and we have discounted prices for patients W/O insurance. We provide Reports, read by Cardiologist and Radiologist. We provide Top notch friendly Technicians, with State of the art Ultrasound Equipment. Most Doctors send their patients to out patient facilities, like Hospitals, Radiology and Cardiology centers. Instead of sending these patients out, they can schedule them for an "in house" office visit to have these exams. Deal point: Better Patient retention. Most of the time it’s more convenient for the patients to come to the office. It’s a more familiar, friendly environment. We provide Reports read by Board Certified Cardiologist/Radiologist between 1-3 Business days. The Doctor receives Rental income for unused office space. (Call for more info) 1) Better patient retention. 2) Reports in 1-3 business days 3) No Expense for Doctors to expand their services 4) Extra office Revenue 5) Work with a Fully accredited Quality Ultrasound company that have been in business for a collective of 20 Years. (References are available upon request). Please Call/Text 917 5 8 8 8 8 7 7

Specialities

Price category
$ (0-10)

Women with congenital hypothyroidism were more likely to experience hemorrhaging in the second and third trimesters, according to a study in The Journal of Clinical Endocrinology and Metabolism. The study included 207 women in a retrospective group and 174 in a prospective group, as well as a 7,425-patient reference group. The bleeding risk was found in both hypothyroid groups, while increased risks including gestational hypertension and preterm birth were seen only in the prospective group.

Published on 2014-12-15 04:05:37 GMT

Prolactinoma patients taking cabergoline may not need to have annual echocardiograms, according to a study published in The Lancet Diabetes & Endocrinology. However, the findings do support regular echocardiograms for those patients who take cabergoline at a high dose or for long periods of time and for patients with an audible heart murmur.

Published on 2014-12-15 04:05:05 GMT

Breast ultrasound scans that followed negative mammograms do not substantially increase cancer detection, according to a study reported in the Annals of Internal Medicine. But the authors did not rule out the prospect that follow-up with the right tool could save more lives. Another study reported at the Radiological Society of North America meeting compared tomosynthesis with mammography and found a significant increase in cancer detection using tomosynthesis to screen women with dense breasts

Published on 2014-12-15 04:04:15 GMT

A Marketsand Markets report predicts that the diagnostic imaging markets in Brazil, Russia, India and China will reach $7.6 billion by 2018, with ultrasound advancing fastest at a compound annual growth rate of 11.4%. The trend is expected to be influenced by the emergence of lower-cost imaging systems, the aging population and widespread prevalence of cancer and heart disease, as well as private-sector funding for infrastructure.

Published on 2014-12-09 19:56:41 GMT

Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally. China is expected to maintain its 2nd position in the forecasting period due to hefty number of breast cancer cases. Worldwide Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market are also growing year on year.

Published on 2015-02-05 14:03:17 GMT

We are a mobile ultrasound company, so we come to you and your clinic at a time, during the week, that is most convenient to you and your patient’s schedule. We can arrange visits to your clinic that are convenient for you, and your patients seven days a week, without an increase in fees for Saturday, or Sunday assignments. We are unlike any other mobile ultrasound company in that we have total dedication to you and your practice. Our professionalism will provide comfort and assurance to you and your patients.

Published on 2014-09-10 17:29:33 GMT

Data presented at the Radiological Society of North America meeting showed 88% of chest X-rays for pediatric patients did not change the course of care, suggesting that children might be undergoing unnecessary X-rays. The majority of scans were ordered for unexplained fainting, vomiting or dizziness.

Published on 2014-12-09 19:55:33 GMT

Peace to you all on this Thanksgiving!!!

Published on 2011-11-24 04:51:23 GMT

Please like our page

Published on 2012-03-21 15:49:37 GMT

Physicians are increasingly turning to imaging for diagnosis of appendicitis, transforming it into standard care for suspected cases. Physicians may choose ultrasound, CT or both. Experts say each modality has merits, but ultrasound's advantages -- including lower cost and lack of radiation -- are persuasive. "The bottom line is that it depends on whether the ultrasound technologist and radiologist have the skill and experience to perform the exam," says Dr. Robert Orth of Texas Children's Hospital. One study linked an ultrasound-first approach with estimated savings of $24.9 million annually in the U.S.

Published on 2014-11-24 01:33:24 GMT

Multiple ultrasound features likely best for determining need for thyroid biopsy. Ultrasound is important in evaluating thyroid nodules, but researchers who analyzed multiple studies found there is no single ultrasound characteristic that will accurately diagnose a malignancy. However, they say combined ultrasound characteristics can likely indicate who needs biopsy. The study published in the journal Thyroid identified microcalcifications, central vascularization, irregular margins and a more vertical shape as having the best specificity

Published on 2015-07-31 19:11:01 GMT

Tumor Ablation Demanding Due to Number of Cancer Patients and Cancer Treatments Tumor Ablation Market Projected to Reach $462.0 Million by 2020. Due to Growing Investment in healthcare sector. Factors such as growing geriatric population across world, increasing population base of cancer patients, technological advancements in ablation devices, increasing number of hospitals & surgical and ablation centers, increasing demand for minimally invasive cancer treatment procedures. Moreover, based on type of departments, global tumor ablation market is classified into three segments, namely, interventional radiology, surgery, and oncology. Cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are key factors for growth. North America holds the largest share of tumor ablation market, followed by Europe. However, APAC market is expected to grow at highest CAGR to 2020. Single User @ US$4650.

Published on 2015-10-05 17:55:35 GMT

Worldwide Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast to 2018. Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally. China is expected to maintain its 2nd position in the forecasting period due to hefty number of breast cancer cases. Worldwide Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market are also growing year on year. Worldwide Breast Cancer Screening population is expected to be little less than 250 Million by 2018. For 2013; China contributes the largest pool of patients followed by United States. Both these countries control double digit population share. Brazil, Japan and Germany occupy the 3rd, 4th, & 5th position respectively. This is our 4th report on Cancer Sector. Renub Research study titled “Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide” analyzes the worldwide market for breast cancer mammography screening market, Breast cancer MRI screening market and breast cancer ultrasound screening market. This report studies separate comprehensive analytics for the 20 countries: United States, Canada, European Countries (United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland), Asian countries (India, China, Japan, Korea, Singapore, Thailand, Malaysia and Brazil), Australia and New Zealand. Price for single user license is USD 1490

Published on 2015-06-11 01:46:15 GMT

Ultrasound predicts thyroid malignancy and distinguishes between benign and malignant thyroid nodules more reliably than elastography, according to research discussed at the American Thyroid Association meeting. However, combining both techniques was the best approach to identifying candidates for fine needle aspiration.

Published on 2014-12-09 19:53:50 GMT

Vitamin D supplementation in pregnant women improves bone mass in offspring. Children born to mothers receiving vitamin D supplementation during pregnancy are more likely to have a higher bone mass if born during the winter months, according to recent study findings presented at The American Society for Bone and Mineral Research Annual Meeting. In a randomized, double-blind, placebo-controlled study testing whether the offspring of mothers supplemented with vitamin D have a higher bone mass than the offspring of mothers who were not supplemented, the researchers also found that mothers in the supplement group did not experience a seasonal decline in vitamin D levels. Cyrus Cooper, OBE, MA, DM, FRCP, FFPH, FMedSci, director of the MRC life course epidemiology unit at University of Southampton, and colleagues analyzed data from 954 pregnant women participating in the MAVIDOS study in the U.K. Women underwent an ultrasound and vitamin D measurements at 12 weeks gestation before being randomly assigned to either 1,000 IU oral vitamin D (n = 477) or matching placebo (n = 477) at 14 weeks gestation. Vitamin D levels were measured again at 14 weeks and 34 weeks gestation. Within 2 weeks of birth, infants underwent whole-body DXA scans to measure bone mineral content; DXA information was available for 665 infants. Researchers found that whole body bone mineral content was greater for infants born to mothers in the supplement group, though the measurements were not significant (61.6 g vs. 60.5 g).

Published on 2015-10-21 01:41:29 GMT

Diastolic dysfunction progresses more quickly in patients with RA. Compared with the general population, diastolic dysfunction developed more rapidly in patients with rheumatoid arthritis during a 5-year period, according to research by John M. Davis III, MD, and colleagues, presented at the European League Against Rheumatism Annual European Congress of Rheumatology. The study comprised 160 patients with rheumatoid arthritis (RA) and 1,391 participants without RA form the Rochester Epidemiology Project. The mean age of patients with RA was 58.5 years compared with 61.1 years in the non-RA group, and 76.3% of the patients with RA were women compared with 50.6% of the non-RA group. John M. Davis, III Patients were evaluated at baseline and at approximately 4 years’ or 5 years’ follow-up. During both visits, patients were examined by a registered diagnostic cardiac sonographer who used pulse wave and tissue Doppler echocardiography to evaluate structural and hemodynamic status of each participant. Assessments followed guidelines from the American Society of Echocardiography, and linear regression models adjusted for age and sex were used to detect differences between patients with RA and the non-RA cohort. Significant acceleration of the A velocity was observed among patients with RA compared with participants without RA, and the mean E/A ratio decreased more quickly in patients with RA. In both groups over time, the e’ velocity decreased and the E/e’ ratio increased, but the difference did not reach statistical significance, according to the researchers. – by Shirley Pulawski

Published on 2015-07-31 19:05:24 GMT

Ultrasound Accurate for Groin Hernia Diagnosis High accuracy seen for both detecting presence, type hernia MONDAY, May 11, 2015 (HealthDay News) -- Ultrasound accurately diagnoses groin hernias, according to a study published online May 6 in the Journal of Clinical Ultrasound. Ryan Ka Lok Lee, from the Prince of Wales Hospital in Hong Kong, and colleagues retrospectively evaluated 172 groin ultrasound results from 151 patients (101 men; mean age, 59 years). The accuracy of ultrasound in diagnosing the presence and type of groin hernia was determined as was any change in the accuracy of ultrasound over time (January 2002 through December 2010 [54 groins] versus January 2011 through December 2012 [118 groins]). The researchers identified 119 groin hernias diagnosed using ultrasound. Limited magnetic resonance imaging and computed tomography scanning was performed on all patients who had had positive results for hernia on ultrasound but did not undergo surgery (11 patients) and on most patients whose ultrasound was negative (48 patients). The overall rates of sensitivity and specificity of ultrasound for diagnosing the presence of groin hernia were 96 and 96 percent, respectively. These rates improved from 92 and 88 percent before 2011 to 98 and 100 percent starting in 2011. The overall accuracy for diagnosing groin hernia type was 96 percent, which also improved from 91 to 98 percent from prior to 2011 to beginning in 2011. "Ultrasound is highly accurate at diagnosing the presence and type of groin hernia," the authors write.

!-- Global site tag (gtag.js) - Google Analytics -->